Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease
Biochemical and Biophysical Research Communications · 2026-09 · 831 · 154287
DOI: 10.1016/j.bbrc.2026.154287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Jie Ling und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Hauptthemen laut MEDLINE: Digoxin, Hypoxia-Inducible Factor 1, alpha Subunit, Inflammation, Graves Ophthalmopathy. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province.
Abstract (Originalsprache)
BACKGROUND Thyroid eye disease (TED) is characterized by orbital inflammation and fibrosis, with a hypoxic microenvironment implicated in disease pathogenesis. OBJECTIVE To determine whether hypoxia-inducible factor-1α (HIF-1α) mediates hypoxia-induced inflammation and fibrosis in TED, and whether the HIF-1α inhibitor digoxin suppresses these processes. METHODS Serum HIF-1α was measured by ELISA in TED patients (n = 12) and healthy controls (n = 7). Primary orbital fibroblasts (OFs) from TED patients were transduced with lentiviral HIF-1α or exposed to hypoxia (1% O2). Inflammatory and fibrotic markers were assessed by qRT-PCR, western blotting, and ELISA. STAT3 phosphorylation and GSDME-mediated pyroptosis were examined. Digoxin (1.5-6 nM) was tested for its ability to reverse HIF-1α-induced changes. RESULTS Serum HIF-1α was significantly elevated in TED patients. HIF-1α overexpression recapitulated hypoxia-induced effects, upregulating IL-6, IL-8, CCL2, CCL8, CXCL1, CXCL2, IL-1β, TIMP1, α-SMA, and COL1A1, increasing STAT3 phosphorylation and activating GSDME-mediated pyroptosis. Digoxin dose-dependently suppressed HIF-1α-driven inflammatory and fibrotic responses, reduced STAT3 phosphorylation, and attenuated cleaved caspase-3 and GSDME-NT expression. CONCLUSIONS HIF-1α is a critical downstream mediator of hypoxia-induced inflammation and fibrosis in TED, acting through STAT3 and GSDME-mediated pyroptosis. Pharmacological inhibition of HIF-1α by digoxin reverses these changes, positioning digoxin as a promising therapeutic candidate for TED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, 510060, China.
- Department of Ophthalmology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China; Engineering Research Centre of Assistive Technology for Visual Impairment, Fujian, Province University,…
- School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, 510060, China. Electronic address: yanghuas…
- Department of Ophthalmology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, China. Electronic address: hlijuan111@163.com.
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, 510060, China. Electronic address: rongxinc…
Förderung
- National Natural Science Foundation of China
- Science and Technology Planning Project of Guangdong Province
Zitieren
APA
Ling, J., Gong, C., Ye, H., Tang, M., Wang, D., Gao, X., Xing, C., Wu, G., Li, X., Bi, S., Yang, H., Huang, L., & Chen, R. (2026). Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease. Biochemical and Biophysical Research Communications, 831, 154287. https://doi.org/10.1016/j.bbrc.2026.154287
Vancouver
Ling J, Gong C, Ye H, Tang M, Wang D, Gao X, et al. Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease. Biochemical and Biophysical Research Communications. 2026;831:154287. doi:10.1016/j.bbrc.2026.154287
BibTeX
@article{Ling2026,
author = {Ling, Jie and Gong, Chengzhen and Ye, Huijing and Tang, Mingjun and Wang, Dongliang and Gao, Xiuyun and Xing, Chenqi and Wu, Guangsen and Li, Xinyu and Bi, Shaowei and Yang, Huasheng and Huang, Lijuan and Chen, Rongxin},
title = {Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
volume = {831},
pages = {154287},
doi = {10.1016/j.bbrc.2026.154287}
}
EUVIMED